Filed: 2/15/2024ACC: 0000950123-24-002647
📋 What this filing means
BLUE OWL CAPITAL HOLDINGS LP filed this quarterly 13F‑HR report disclosing 43 equity positions with a total reported market value of $418.34M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
43
Positions
$418.34M
Total AUM (reported)
51.05M
Total Shares
Allocation by class
COM$287.57M68.7%
COM CL A$62.91M15.0%
COM SER A$33.38M8.0%
COM NEW$8.46M2.0%
CL A$6.96M1.7%
SHS$4.84M1.2%
CLASS A ORD$3.93M0.9%
Portfolio Concentration
Top 3$143.24M34.2%
4–10$163.49M39.1%
11–25$92.21M22.0%
Rest$19.39M4.6%
Top 3 weight
34.2%
Top 10 weight
73.3%
Voting Authority Distribution
Total shares with voting rights: 0.00
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other43
Dominant voting typeNone · 0.0% of voting shares
Institutional Holdings43
Rows:
PLIANT THERAPEUTICS INC
DFNDShares3M
TypeSH
Market value$54.41M
13.01%
Sole
0.00
Shared
0.00
None
0.00
ROBINHOOD MKTS INC
DFNDShares4.24M
TypeSH
Market value$53.98M
12.90%
Sole
0.00
Shared
0.00
None
0.00
CULLINAN ONCOLOGY INC
DFNDShares3.42M
TypeSH
Market value$34.85M
8.33%
Sole
0.00
Shared
0.00
None
0.00
TOURMALINE BIO INC
DFNDShares1.33M
TypeSH
Market value$32.39M
7.74%
Sole
0.00
Shared
0.00
None
0.00
KLAVIYO INC
DFNDShares1.20M
TypeSH
Market value$31.46M
7.52%
Sole
0.00
Shared
0.00
None
0.00
BLUE OWL CAPITAL CORPORATION
DFNDShares2.05M
TypeSH
Market value$30.19M
7.22%
Sole
0.00
Shared
0.00
None
0.00
REPARE THERAPEUTICS INC
DFNDShares3.12M
TypeSH
Market value$22.79M
5.45%
Sole
0.00
Shared
0.00
None
0.00
ACELYRIN INC
DFNDShares2.29M
TypeSH
Market value$17.11M
4.09%
Sole
0.00
Shared
0.00
None
0.00
LARIMAR THERAPEUTICS INC
DFNDShares3.41M
TypeSH
Market value$15.54M
3.71%
Sole
0.00
Shared
0.00
None
0.00
KEROS THERAPEUTICS INC
DFNDShares352.63K
TypeSH
Market value$14.02M
3.35%
Sole
0.00
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
DFNDShares263.24K
TypeSH
Market value$12.59M
3.01%
Sole
0.00
Shared
0.00
None
0.00
ENGENE HOLDINGS INC
DFNDShares1.23M
TypeSH
Market value$11.40M
2.72%
Sole
0.00
Shared
0.00
None
0.00
SYROS PHARMACEUTICALS INC
DFNDShares1.49M
TypeSH
Market value$8.46M
2.02%
Sole
0.00
Shared
0.00
None
0.00
DISC MEDICINE INC
DFNDShares140.26K
TypeSH
Market value$8.10M
1.94%
Sole
0.00
Shared
0.00
None
0.00
E2OPEN PARENT HOLDINGS INC
DFNDShares1.65M
TypeSH
Market value$7.25M
1.73%
Sole
0.00
Shared
0.00
None
0.00
BLUEPRINT MEDICINES CORP
DFNDShares71.89K
TypeSH
Market value$6.63M
1.59%
Sole
0.00
Shared
0.00
None
0.00
TOAST INC
DFNDShares5.89M
TypeSH
Market value$6.04M
1.44%
Sole
0.00
Shared
0.00
None
0.00
INOZYME PHARMA INC
DFNDShares1.27M
TypeSH
Market value$5.41M
1.29%
Sole
0.00
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
DFNDShares568.38K
TypeSH
Market value$4.89M
1.17%
Sole
0.00
Shared
0.00
None
0.00
COMPASS THERAPEUTICS INC
DFNDShares2.83M
TypeSH
Market value$4.41M
1.06%
Sole
0.00
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
DFNDShares65K
TypeSH
Market value$3.93M
0.94%
Sole
0.00
Shared
0.00
None
0.00
IKENA ONCOLOGY INC
DFNDShares1.95M
TypeSH
Market value$3.85M
0.92%
Sole
0.00
Shared
0.00
None
0.00
DIREXION SHS ETF TR
DFNDShares340K
TypeSH
Market value$3.29M
0.79%
Sole
0.00
Shared
0.00
None
0.00
OMEGA THERAPEUTICS INC
DFNDShares1.06M
TypeSH
Market value$3.18M
0.76%
Sole
0.00
Shared
0.00
None
0.00
OVID THERAPEUTICS INC
DFNDShares864.82K
TypeSH
Market value$2.78M
0.67%
Sole
0.00
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
PLIANT THERAPEUTICS INCDFND | COM | 3M | SH | $54.41M 13.01% | 0.00 | 0.00 | 0.00 |
ROBINHOOD MKTS INCDFND | COM CL A | 4.24M | SH | $53.98M 12.90% | 0.00 | 0.00 | 0.00 |
CULLINAN ONCOLOGY INCDFND | COM | 3.42M | SH | $34.85M 8.33% | 0.00 | 0.00 | 0.00 |
TOURMALINE BIO INCDFND | COM | 1.33M | SH | $32.39M 7.74% | 0.00 | 0.00 | 0.00 |
KLAVIYO INCDFND | COM SER A | 1.20M | SH | $31.46M 7.52% | 0.00 | 0.00 | 0.00 |
BLUE OWL CAPITAL CORPORATIONDFND | COM | 2.05M | SH | $30.19M 7.22% | 0.00 | 0.00 | 0.00 |
REPARE THERAPEUTICS INCDFND | COM | 3.12M | SH | $22.79M 5.45% | 0.00 | 0.00 | 0.00 |
ACELYRIN INCDFND | COM | 2.29M | SH | $17.11M 4.09% | 0.00 | 0.00 | 0.00 |
LARIMAR THERAPEUTICS INCDFND | COM | 3.41M | SH | $15.54M 3.71% | 0.00 | 0.00 | 0.00 |
KEROS THERAPEUTICS INCDFND | COM | 352.63K | SH | $14.02M 3.35% | 0.00 | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INDFND | COM | 263.24K | SH | $12.59M 3.01% | 0.00 | 0.00 | 0.00 |
ENGENE HOLDINGS INCDFND | COM | 1.23M | SH | $11.40M 2.72% | 0.00 | 0.00 | 0.00 |
SYROS PHARMACEUTICALS INCDFND | COM NEW | 1.49M | SH | $8.46M 2.02% | 0.00 | 0.00 | 0.00 |
DISC MEDICINE INCDFND | COM | 140.26K | SH | $8.10M 1.94% | 0.00 | 0.00 | 0.00 |
E2OPEN PARENT HOLDINGS INCDFND | COM CL A | 1.65M | SH | $7.25M 1.73% | 0.00 | 0.00 | 0.00 |
BLUEPRINT MEDICINES CORPDFND | COM | 71.89K | SH | $6.63M 1.59% | 0.00 | 0.00 | 0.00 |
TOAST INCDFND | CL A | 5.89M | SH | $6.04M 1.44% | 0.00 | 0.00 | 0.00 |
INOZYME PHARMA INCDFND | COM | 1.27M | SH | $5.41M 1.29% | 0.00 | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCDFND | COM | 568.38K | SH | $4.89M 1.17% | 0.00 | 0.00 | 0.00 |
COMPASS THERAPEUTICS INCDFND | COM | 2.83M | SH | $4.41M 1.06% | 0.00 | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSDFND | CLASS A ORD | 65K | SH | $3.93M 0.94% | 0.00 | 0.00 | 0.00 |
IKENA ONCOLOGY INCDFND | COM | 1.95M | SH | $3.85M 0.92% | 0.00 | 0.00 | 0.00 |
DIREXION SHS ETF TRDFND | DAILY S&P BIOTEC | 340K | SH | $3.29M 0.79% | 0.00 | 0.00 | 0.00 |
OMEGA THERAPEUTICS INCDFND | COMMON STOCK | 1.06M | SH | $3.18M 0.76% | 0.00 | 0.00 | 0.00 |
OVID THERAPEUTICS INCDFND | COM | 864.82K | SH | $2.78M 0.67% | 0.00 | 0.00 | 0.00 |
Page 1 of 2